Currently, no blood test can directly identify and diagnose pancreatic cancer. However, the condition can produce some unusual results during other blood tests, indicating the need to investigate ...
The findings contribute to validating systemic administration as an effective delivery approach, demonstrating significant tumor growth reduction in orthotopic pancreatic cancer models ...
Pancreatic cancer develops when abnormal cells in the pancreas grow and divide uncontrollably, forming a tumor. The pancreas is a glandular organ nestled between the stomach and the spine that ...
Pancreatic cancer, one of the most formidable, could soon see its treatment transformed. Researchers have identified an enzyme, Mical2, which plays a central role in the progression of this disease.
Solaiyappan et. al apply AI to analyze metabolic information contained in 1H magnetic resonance spectra to distinguish between pancreatic cancer and non-disease participants. This work presents a ...
BASKING RIDGE, N.J. - Lisata Therapeutics, Inc. (NASDAQ:LSTA), a clinical-stage biotech company with a market capitalization of $23 million, in collaboration with WARPNINE Incorporated, has announced ...
Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria Background: The G protein-coupled receptor 55 (GPR55) is part of an expanded endocannabinoid system (ECS ...